The Intelligent Drug Discovery Market published by Emergen Research, is methodically curated by our team of analysts, keeping readers’ understanding in mind, and includes a wide-ranging database of industry distribution. The report takes a closer look at the historical and current market scenarios to accurately predict the global Intelligent Drug Discovery market outlook over the forecast duration (2021-2027).
The growing adoption of cloud-based applications and the expiration of patented drugs will pave the way for new generic and OTC medicines, which will influence market demand. The advancement in deep learning and machine learning will allow pharmaceutical companies to reorganize molecule binding properties with high accuracy.
To know more about the report @https://www.emergenresearch.com/industry-report/intelligent-drug-discovery-market
Regional Overview:
The global Intelligent Drug Discovery market has been categorized on the basis of key geographical regions into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. It evaluates the presence of the global Intelligent Drug Discovery market in the major regions with regards to market share, market size, revenue contribution, sales network and distribution channel, and other key elements.
Leading companies profiled in the report:
IBM Corporation, Microsoft Corporation, Google, NVIDIA Corporation, Cloud Pharmaceuticals, Inc., Atomwise, Inc., Insilico Medicine, Exscientia, Bioage, and Envisagenics, among others.
Key insights presented in the report:
- Market revenue shares by major business players, by type, by application, and market scope of global Intelligent Drug Discovery market
- Sales revenue by key players and new entrants
- Competitive analysis of the key players including aspects such as company overview, product or services specification, vendors, and buyers.
- Recent mergers, acquisitions, product launches, recent investments, and joint ventures
- Regional analysis to provide insight to recent trends and opportunities
The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.
Intelligent Drug Discovery Market segmentation
For the purpose of this report, Emergen Research has segmented into the global Intelligent Drug Discovery Market on the offering, technology, application, end-user, and region:
- Offering Outlook (Revenue, USD Billion; 2017-2027)
- Software
- Services
- Technology Outlook (Revenue, USD Billion; 2017-2027)
- Machine Learning
- Supervised Learning
- Deep Learning
- Reinforcement Learning
- Unsupervised Learning
- Other Technologies
- Machine Learning
- Application Outlook (Revenue, USD Billion; 2017-2027)
- Neurodegenerative Diseases
- Metabolic Diseases
- Immuno-Oncology
- Cardiovascular Disease
- Others
- End-User Outlook (Revenue, USD Billion; 2017-2027)
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Research Centers and Academic & Government Institutes
The report focuses on current and future market growth, technological advancements, volume, raw materials, and profiles of the key companies involved in the market. The report provides valuable insights to the stakeholders, investors, product managers, marketing executives, and other industry professionals.
The report also offers key insights about top companies in the market along with a thorough SWOT analysis, Porter’s Five Forces analysis, and feasibility analysis to offer competitive edge to the readers. The report focuses on the recent trends, major challenges and opportunities, and limitations pertaining to the ongoing pandemic.
Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs.
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
